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A B S T R A C T
Vulvovaginal candidiasis (VVC) caused by Candida albicans is a common disease worldwide. A very important C.
albicans virulence factor is its ability to form biofilms on epithelium and/or on intrauterine devices promoting
VVC. It has been shown that VVC has a hormonal dependency and that progesterone affects virulence traits of C.
albicans cells. To understand how the acidic environment (pH 4) and progesterone (either alone and in com-
bination) modulate C. albicans response during formation of biofilm, a transcriptomic analysis was performed
together with characterization of the biofilm properties. Compared to planktonic cells, acidic biofilm-cells ex-
hibited major changes in their transcriptome, including modifications in the expression of 286 genes that were
not previously associated with biofilm formation in C. albicans. The vast majority of the genes up-regulated in the
acidic biofilm cells (including those uniquely identified in our study) are known targets of Sfl1, and consistently,
Sfl1 deletion is herein shown to impair the formation of acidic biofilms (pH 4). Under the acidic conditions used,
the presence of progesterone reduced C. albicans biofilm biomass and structural cohesion. Transcriptomic
analysis of biofilms developed in the presence of progesterone led to the identification of 65 down-regulated
genes including, among others, the regulator Tec1 and several of its target genes, suggesting that the function of
this transcription factor is inhibited by the presence of the hormone. Additionally, progesterone reduced the
susceptibility of biofilm cells to fluconazole, consistent with an up-regulation of efflux pumps. Overall, the
results of this study show that progesterone modulates C. albicans biofilm formation and genomic expression
under acidic conditions, which may have implications for C. albicans pathogenicity in the vaginal environment.
1. Introduction
Vulvovaginal candidiasis (VVC) affects millions of women every
year and is considered to be an important public health problem. It is
estimated that approximately 70–75 % of women will experience an
episode of VVC in their lifetime (Sobel, 2007). Although VVC is not
usually a life-threatening condition, the vaginal tract constitutes a pu-
tative access route to the bloodstream and therefore infections of this
niche have the potential to result in disseminated infections, particu-
larly in immunocompromised patients (Ascioglu et al., 2002). Candida
species are opportunistic microbes of the vaginal commensal micro-
flora, and under certain conditions, the usually symptomless coloniza-
tion progresses into infection (Beigi et al., 2004). Despite an increased
isolation of non-Candida albicans Candida species (NCAC) in women
with VVC (Ahmad and Khan, 2009; Cetin et al., 2007), Candida albicans
is still the most prevalent species (Amouri et al., 2011; Fan et al., 2008;
Vermitsky et al., 2008). The ability of C. albicans to form biofilms is an
important virulence factor as it confers unique phenotypic character-
istics compared to its planktonic counterpart cells, including significant
resistance to antifungal agents and host defense mechanisms while also
providing protection against other physical and chemical stresses
(Donlan and Costerton, 2002). In the vaginal environment, Candida
species can form biofilms on the vaginal epithelium (Harriott et al.,
2010) and also on intrauterine devices (IUDs) thereby promoting VVC
(Chassot et al., 2008; Lal et al., 2008). The ability of Candida species to
form biofilms in the vaginal environment is an important clinical pro-
blem, since the recalcitrant nature of biofilms to currently used anti-
fungals prevents definitive eradication of these microbes from the va-
ginal lumen thus contributing to the recurrence of VVC (Harriott et al.,
2010).
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The development of VVC has been associated with the disturbance
of the hormonal vaginal environment resulting from behavioral or other
host-related factors such as pregnancy, hormone replacement therapy,
and use of oral contraceptives or IUDs (Sobel, 2007). It is thought that
progesterone contributes to VVC development by stimulating the pro-
duction of glycogen by epithelial cells (Dennerstein and Ellis, 2001;
Špaček et al., 2007) and inhibiting certain traits of the innate and
adaptive immune response (Keller et al., 2007). Besides these effects on
the host it has been also shown that progesterone has direct effects on
the physiology of Candida cells. Several Candida species such as C. al-
bicans, Candida guilliermondii, Candida krusei, Candida parapsilosis and
Candida tropicalis have corticosterone receptors with high affinity for
progesterone (Loose et al., 1983; Skowronski and Feldman, 1989). A
transcriptional survey of the effect of progesterone on C. albicans
planktonic cells identified activation of stress response pathways, in-
cluding the induction of genes involved in host immune and drugs re-
sponse (Banerjee et al., 2007). Banerjee et al. (2007) also reported that
progesterone decreases C. albicans drug susceptibility and found higher
MIC for fluconazole and ketoconazole when C. albicans planktonic cells
are exposed to progesterone. In a previous study, we have shown (Alves
et al., 2014) that progesterone, at pregnancy levels, reduces the ability
of C. albicans strains to form biofilms. This unexpected finding fostered
the present work in which we aimed to deepen the current under-
standing on how progesterone modulates the process of C. albicans
biofilm formation at the vaginal acidic pH, something that has not been
examined before and that is essential for a full understanding of the
pathogenesis of this species in the acidic vaginal tract.
2. Material and methods
2.1. Strains and growth conditions
The reference strain C. albicans SC5314 was the main strain used in
this work. Additionally, some experiments were carried out using C.
albicans mutant strains and their respective parent. All the strains are
listed in Table 1.
For each experiment the strains were subcultured on Sabouraud
dextrose agar medium (SDA; Merck, Darmstadt, Germany) for 48 h at
37 °C. An inoculum from the SDA plate was suspended in 25 mL of
Sabouraud dextrose broth (SDB; Merck, Darmstadt, Germany) and in-
cubated for 18 h under agitation (120 rev/min) at 37 °C. Under these
conditions the cells were found to be at the beginning of stationary
phase. After incubation, the cells were harvested by centrifugation at
3000 g for 10 min at 4 °C and washed twice with 15 mL of Phosphate
Buffered Saline (PBS; pH 7). Pellets were suspended in Roswell Park
Memorial Institute medium (RPMI) (Sigma-Aldrich, St Louis, MO,
USA), buffered with MOPS (3-(N-morpholino) propane sulfonic acid)
and adjusted to pH 4 with HCl. The cell density was further adjusted to
1 × 107 cells/mL for each experiment, using a Neubauer haemocyt-
ometer (Marienfeld, Lauda-Königshofen, Germany).
2.2. Effect of progesterone on C. albicans planktonic growth
A stock solution of progesterone (Sigma-Aldrich, St Louis, MO, USA)
at 10 mM was prepared on ultrapure water and stored at −20 °C to be
used in all experiments. C. albicans SC5314 cells from the pre-inoculum
were cultivated in RPMI at pH 4, either supplemented or not with 2 μM
of progesterone (Alves et al., 2014). Cultures of C. albicans cells (1 ×
107 cells/mL with and without progesterone) were placed in 25 mL
Erlenmeyer flasks, maintained at 37 °C with agitation (120 rev/min)
and the increase in optical density at 600 nm was measured over time
using a microtiter plate reader (Bio-Tek Synergy HT, Izasa, Winooski,
VT, USA). The optical density of the initial cultures was 0.01. The re-
sults were presented as optical density over 30 h of growth.
2.3. Effect of progesterone on C. albicans biofilm formation
2.3.1. Biofilm formation
To study the effect of progesterone on biofilm formation, biofilms
were developed in presence and absence of progesterone as described
by Alves et al. (2014). Briefly, suspensions (1 × 107 cells/mL) of C.
albicans SC5314 cells from the pre-inoculum were prepared in RPMI at
pH 4, either supplemented or not with 2 μM of progesterone, and placed
into wells of 96-wells polystyrene microtiter plates (Orange Scientific,
Braine-l`Alleud, Belgium) (200 μL per well). The plates were incubated
for 24 h at 37 °C under agitation (120 rev/min). After incubation, the
medium was aspirated and non-adherent cells were removed by
washing the biofilms with 200 μL of PBS. The analyses of the biofilms
were performed in triplicate (biofilms formed from the same pre-in-
oculum) and in three independent assays (biofilms formed from pre-
inoculums independently prepared).
2.3.2. Biofilm cultivable cells determination
The number of cultivable cells on biofilms grown with and without
progesterone was determined by measuring colony forming units
(CFUs) (Silva et al., 2009). Briefly, biofilms were scraped from the
microtiter plates wells with 200 μL of PBS and the suspensions were
vigorously vortexed for 2 min to disaggregate cells. Serial dilutions in
PBS of the resuspended biofilms were plated on SDA and incubated for
24 h at 37 °C. After incubation, the number of colonies on the SDA
plates was counted and the results were presented as total of colony
forming units (CFUs) per unit area of microtiter plate well (Log (CFUs/
mL)/cm2).
2.3.3. Biofilm total biomass quantification
Biofilms’ total biomass, formed with and without progesterone,
were quantified using crystal violet (CV) staining methodology (Silva
et al., 2009). Biofilms were fixed on the microtiter plates wells with 200
μL of methanol, which was removed after 15 min. The microtiter plates
were allowed to dry at room temperature and biofilms were stained by
the addition of 200 μL of CV (1%, v/v) to each well. After 5 min, CV was
removed and biofilms were washed twice with sterile water to remove
the excess of stain. Finally, 200 μL of acetic acid (33 %, v/v) were added
to each well to release and dissolve the stain and the absorbance of the
obtained solutions was measured in a microtiter plate reader (Bio-
TekSynergy HT, Izasa, Winooski, VT, USA) at 570 nm. The results were
presented as absorbance per unit area of microtiter plate well (Absor-
bance CV/cm2).
2.3.4. Biofilm metabolic activity determination
A XTT reduction assay (Hawser, 1996) was used to determine the
metabolic activity of the biofilms formed in the presence and absence of
Table 1
Candida albicans strains used in this study.
Strain name Parent Relevant genotype Reference
SC5314 Prototrophic Lab collection
SN76 SC5314 arg4Δ/arg4Δ, his1Δ/his1Δ, ura3Δ-iro1Δ::λimm434/ura3Δ-iro1Δ::λimm434 (Noble and Johnson, 2005)
sfl1Δ/sfl1Δ SN76 sfl1Δ::ARG4/sfl1Δ::HIS1 (Znaidi et al., 2013)
tec1Δ/tec1Δ SN76 tec1Δ::ARG4/tec1Δ::HIS1 (Znaidi et al., 2013)
brg1Δ/brg1Δ SN76 brg1Δ::ARG4/brg1Δ::HIS1 (Znaidi et al., 2013)
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progesterone. A 200 μL aliquot of a solution containing 100 μg/μL of
XTT (2, 3-(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) car-
bonyl]-2H-tetrazolium hydroxide) (Sigma-Aldrich, St Louis, MO, USA)
and 10 μg/μL of PMS (phenazine methosulfate) (Sigma-Aldrich, St
Louis, MO, USA) was added to wells with developed biofilms. The
plates were incubated for 3 h in the dark, at 37 °C under agitation (120
rev/min). Then, 150 μL of supernatant of each well were transferred to
a new microtiter plate reader (Bio-Tek Synergy HT, Izasa, Winooski,
VT, USA) and the colorimetric changes were measured at 490 nm. The
absorbance values were normalized with respect to the CFUs and are
presented as Absorbance XTT/Log (CFUs/mL).
The metabolic activity of planktonic cells grown as described above,
in presence and absence of progesterone, was also determined at spe-
cific time points up to 24 h. In this case 50 μL aliquot of XTT/PMS was
added to 200 μL of cell suspension and the metabolic activity was
analyzed as described for biofilms.
2.3.5. Biofilm structure analysis
The structure of C. albicans biofilms formed with and without pro-
gesterone was analyzed by scanning electron microscopy (SEM) (Alves
et al., 2014). Biofilms were formed as described above, except on 24-
well polystyrene microtiter plates (Orange Scientific, Braine-l’Alleud,
Belgium) (1 mL of cell suspension per well). Developed biofilms were
dehydrated with ethanol (using 70 % ethanol for 10 min, 95 % ethanol
for 10 min and 100 % ethanol for 20 min), air dried for 20 min and
placed in a desiccator until analysis. Before observation, the base of the
wells was removed and mounted onto aluminum stubs, sputter coated
with gold. Biofilms were then imaged with an S-360 scanning electron
microscope (Leo, MA, Cambridge, USA).
2.3.6. Biofilm cells antifungal susceptibility testing
The susceptibility of C. albicans biofilm cells to fluconazole was
tested using the reference protocol for broth microdilution antifungal
susceptibility testing of yeasts, according to the Clinical and Laboratory
Standards Institute methods (CLSI, 2017). Biofilms developed as
described above, in presence and absence of progesterone, were scraped
from the wells with PBS and the suspensions were vigorously vortexed
for 2 min and centrifuged at 5000 g for 5 min at 4 °C. Pellets were
resuspended in RPMI at pH 4 and the cell suspensions were used to the
antifungal susceptibility tests and minimal inhibitory concentrations
determination (MICs), according to the reference method.
2.4. Transcriptomic analysis
The effect of progesterone on the transcriptome of C. albicans bio-
films was assessed using species-specific DNA microarrays (Bernardo
et al., 2017). For this, the transcriptomes of C. albicans SC5314 cells
present in biofilms grown for 24 h in absence and presence of proges-
terone (2 μM) were compared with the transcriptome of planktonic cells
cultivated for the same time in hormone-free RPMI medium (pH 4). The
experimental setups used to cultivate the cells in planktonic and biofilm
life styles were the same as described above and using 24-well poly-
styrene microtiter plates (1 mL per well). Developed biofilms obtained
after 24 h of cultivation in presence and absence of progesterone were
scraped from the plates with PBS and the suspensions were sonicated
(Ultrasonic Processor, Cole-Parmer, IL, USA) for 30 s at 30 W, to se-
parate the cells from the biofilm matrix (Silva et al., 2009). Then, all
cell suspensions (planktonic and biofilm-forming cells) were cen-
trifuged at 3000 g for 10 min at 4 °C, the supernatants were rejected
and pellets were used for RNA extraction.
2.4.1. RNA extraction
Total RNA extraction was performed using the RiboPure – Yeast Kit
(Life Technologies, Carlsbad, CA, USA), according to the manufacturer’s
protocol. RNA concentration and purity were determined by spectro-
photometry and its integrity was confirmed using an Agilent 2100
Bioanalyzer with an RNA 6000 Nano Assay (Agilent Technologies,
Santa Clara, CA, USA).
Fig. 1. Effect of progesterone on C. albicans
biofilm formation. (A) Cell cultivability de-
termination [Log (CFUs/mL)/cm2], (B) total
biomass quantification (Absorbance CV/cm2),
(C) metabolic activity measurement
(Absorbance XTT/Log (CFUs/mL)) and (D)
scanning electron microscopy images of C. albi-
cans SC5314 biofilms grown 24 h in RPMI at pH
4 in absence (-PRGST) or presence of 2 μM of
progesterone (+PRGST). Error bars represent
standard deviation. Asterisks represent statis-
tical difference between the conditions (**** p-
value ≤0.0001; ** p-value ≤0.01). Original
magnification of panel the images of panel D
was x 1000 and the scale bars correspond to 20
μm.
B. Gonçalves, et al. International Journal of Medical Microbiology 310 (2020) 151414
3
2.4.2. Microarray analysis
cDNA synthesis, hybridization and scanning were performed using
protocols similar to those described previously (Rossignol et al., 2007),
with the exception of that hybridization was carried out using an Agi-
lent hybridization oven at 65 °C for 17 h at 100 rpm. In brief, 6 μg of
total RNA was incubated with 1.4 μg of anchored Oligo(dT)20 primer
(Invitrogen, Carlsbad, CA, USA) in a total volume of 18.5 μL for 10 min
at 70 °C. First-strand buffer (Invitrogen, Carlsbad, CA, USA), 0.5 mM
dATP, dTTP, and dGTP; 50 μM dCTP; 10 mM dithiothreitol; 2 μL Su-
perscript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA); and
2 μL Cy3-dCTP or Cy5-dCTP (Amersham, PA53021 and A55021) were
added to a total volume of 40 μL, incubated at 42 °C for 2 h followed by
1 h at 42 °C with an additional 1 μL of Superscript III. RNA was de-
graded by addition of 1 μL of RNase A at 50 μg/mL and 1 μL of RNase H
at 1 unit/μL and incubated at 37 °C for 30 min. The labelled cDNAs
were purified using a QIAquick PCR purification kit (Qiagen, Hilden,
Germany), using a modified protocol. Samples were prepared for
hybridization using Agilent’s Two-Color Microarray-Based Gene ex-
pression (Quick Amp labelling protocol) and the Gene Expression Hy-
bridization Kit. 10 μL each Cy3-labeled and Cy5-labeled cDNA were
used per array (8 × 15 k, design ID 065138), in a total volume of 50 μL.
Hybridized microarrays were scanned with an Axon 4000B scanner
(Axon Instruments, Union City, CA, USA) and data were acquired with
Gene Pix Pro 5.1 software (Axon Instruments, Union City, CA, USA).
Data was analyzed using the LIMMA package in Bioconductor (www.
bioconductor.org). Three biological replicates and three technical re-
plicates were performed. Lowess normalization and background cor-
rection were applied to each array separately, and quantile normal-
ization was used to allow log ratios to be compared across arrays. Only
genes exhibiting log2FC>1.0 and having an associated p-value below
0.01 were selected for further analysis. The data was submitted to the
Array Express database with the reference E-MTAB-8672.
Table 2
Subset of genes found to be biofilm-regulated (up- and down) in C. albicans cells cultivated 24 h at pH 4. A subset of genes whose expression was found to
increase or decrease (above or below 2-fold) in C. albicans SC5314 biofilms grown 24 h in RPMI at pH 4, in comparison with the transcript levels registered in
planktonic cells cultivated in the same conditions, was selected and are herein shown, while the full list is available on supplementary Table S2. Genes whose
transcription was found to be biofilm-induced or –repressed specifically at the acidic conditions used in this study, are highlighted in grey and among them are
highlighted in bold those previously described as essential to biofilm formation. The biological function indicated is based on the information available at
Candida Genome Database.
Up-regulated genes
Gene Biological function mRNAbiofilm / mRNAplanktonic
ALS1 Cell-surface adhesin 20.17
ECE1 Candida lysin 18.12
CAN2 Basic aminoacid permease 16.91
SOD5 Cu-containing superoxide dismutase 15.01
C1_13130C_A Putative histidine permease 12.59
COX3B Cytochrome c oxidase involved in mitochondrial respiration 10.97
HGT2 Putative MFS glucose transporter 10.57
HYR1 Hyphal cell wall protein involved in biological adhesion 9.87
NAD1 NADH dehydrogenase involved in mitochondrial respiration 9.69
NAD3 NADH dehydrogenase involved in mitochondrial respiration 9.49
C2_10160W_A Secreted protein 9.30
HGT1 High-affinity MFS glucose transporter 9.18
DIP5 Dicarboxylic aminoacid permease 8.97
ATP6 Subunit 6 of the F0 sector of mitochondrial F1F0 ATP synthase 7.84
PRA1 Cell surface protein that sequesters zinc from host tissue 5.88
QDR1 Putative antibiotic resistance transporter 5.71
C7_00490C_A Putative AdoMet-dependent proline methyltransferase 2.93
NPL3 Putative RNA-binding protein 2.63
CSA2 Extracellular-associated protein involved in iron assimilation 2.58
C1_00160C_A Putative nucleolar protein 2.57
ALS5 ALS family adhesin 2.38
NDT80 Meiosis-specific transcription factor 2.28
WOR1 Transcription factor of white-opaque phenotypic switching 2.16
Down-regulated genes
Gene Biological function mRNAbiofilm / mRNAplanktonic
DUR3 High affinity spermidine transporter 0.05
MEP2 Ammonium permease 0.09
JEN2 Dicarboxylic acid transporter 0.11
C2_00180C_A Predicted uricase 0.15
C1_01630W_A Putative mitochondrial complex I intermediate-associated protein 0.15
FDH1 Formate dehydrogenase 0.17
C1_07160C_A Protein conserved among the CTG-clade 0.17
CWH8 Putative dolichyl pyrophosphate (Dol-P-P) phosphatase 0.18
HSP30 Putative heat shock protein 0.18
LAP3 Putative aminopeptidase 0.18
CTN1 Carnitine acetyl transferase 0.18
C2_01660C_A Unknown function 0.18
CCP1 Putative Cytochrome-c peroxidase 0.18
MDH1-1 Predicted malate dehydrogenase precursor 0.18
C5_03770C_A Putative formate dehydrogenase 0.18
C5_03710C_A Unknown function 0.18
DUR1,2 Urea amidolyase involved in response to abiotic stimulus 0.19
ADH2 Alcohol dehydrogenase; 0.19
PGA13 GPI-anchored cell wall protein involved in cell wall synthesis 0.19
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2.5. Measurement of gene transcription based on quantitative real-time PCR
In order to validate some of the results obtained in the microarray
analysis, the expression profile of a set of specific genes (TEC1, CRZ2
and CDR1) was obtained using quantitative real-time PCR (qRT-PCR).
The experimental conditions used to cultivate C. albicans SC5314 cells
and to obtain RNA were the same as those described above for the
transcriptomic analysis. Then, 0.5 μg of total RNA collected from each
sample was used to obtain the complementary DNA (cDNA), using the
iScriptcDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA) according to
the manufacturer’s instructions. cDNA synthesis was performed at 70 °C
for 5 min followed by 42 °C for 1 h and lastly 5 min at 95 °C to stop the
reaction. Approximately 125 ng of the synthesized cDNA were used for
the qRT-PCR. qRT-PCR (CF X96 Real-Time PCR System; Bio-Rad,
Hercules, CA, USA) was used to determine the relative levels of mRNA
transcripts, with the transcript level of ACT1 mRNA used as an internal
control. Primers for the target genes and ACT1 were designed using
Primer3 web software and their sequences are provided in supple-
mentary Table S1. Full-length gene sequences were obtained from the
Candida Genome Database (www.candidagenome.org) (Skrzypek et al.,
2010). The sequence of each primer was compared to the Candida
genome database using BLAST (Altschul et al., 1997), to confirm their
Fig. 2. Functional distribution of genes found
to be biofilm-regulated in C. albicans cells cul-
tivated for 24 h in RPMI at pH 4. The genes
found to be up- or down-regulated in C. albicans
SC5314 biofilms grown 24 h in RPMI at pH 4,
in comparison with the levels found in plank-
tonic cells cultivated in the same conditions,
were clustered according to their biological
function, using MIPS Functional Catalogue da-
tabase (black and white bars correspond to up-
and down-regulated genes, respectively). The
percentages shown correspond to the number
of genes included in each functional class
compared to the total number of up- or down-
regulated genes. Functional categories con-
sidered significantly enriched in the datasets (p-
value< 0.001; taking into consideration the
entire genome of C. albicans SC5314 reference
strain) are indicated with asterisk (asterisk be-
fore or after the class denomination means en-
richment among down- or up-regulated genes,
respectively).
Fig. 3. Proposed transcriptional regulatory network underlying the control of C. albicans biofilm cells after 24 h of cultivation in RPMI at pH 4. The genes found to be
up-regulated in C. albicans SC5314 biofilms formed after 24 h of cultivation in RPMI at pH 4, in comparison with the levels attained in planktonic cells, were clustered
according with the existence of documented regulatory associations with transcription factors mediating the control of transcriptome-wide alterations related with
biofilm formation, according with the information available on the PathoYeastract database. The number of documented targets attributed to each transcription
factor is indicated in brackets inside the black boxes. Only genes having a biological function related with adhesion and/or biofilm formation (or described to be up-
regulated under these conditions) were selected for this analysis, being identified in grey boxes those genes whose deletion was described to abolish biofilm
formation. The results that gave rise to this figure are fully detailed in supplementary Table S3.
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specificity. The specificity of each primer pair for its corresponding
target gene was also confirmed, applying a PCR to genomic DNA ex-
tracted from C. albicans SC5314 planktonic cells, using the various
primer pairs. Then, qRT-PCR was performed using reaction mixtures
consisted of SsoFast EvaGreen Supermix (Bio-Rad, Hercules, CA, USA),
dH2O (Cleaver Scientific Ltd, Warwickshire, UK), cDNA samples and
the primer pair respective to the target gene (50 μM). Negative controls
(dH2O) and non-reverse transcriptase controls (NRT) were also in-
cluded in each run. qRT-PCR was performed at 98 °C for 2 min in the
initial denaturation step, followed by denaturation at 98 °C for 5 s and
primer annealing at 57 °C for 5 s, during 40 cycles. In each cycle a
melting curve was generated, running a dissociation stage at 60 °C, to
verify the amplification product specificity. Control samples were in-
cluded on each plate to ensure that multiple plates could be compared.
The Ct value of each sample was determined and the relative gene
expression levels calculated using the ΔCt method (Livak and
Schmittgen, 2001), being normalized with the internal control gene
(Ctaverage = 23.02± 1.35; three biological replicates). Each reaction
was performed in quadruplicate and mean values of relative expression
were determined for each gene.
2.6. Experiments using C. albicans mutant strains
In order to investigate the role of some genes (SFL1, TEC1and BRG1)
suggested by our microarray analysis to be important to the biofilm
formation in the specific conditions used in this study (pH 4 and pre-
sence of progesterone), C. albicans biofilms of homozygous null mutants
were formed. Mutant and respective parental strains (auxotrophs) used
for these experiments are listed in Table 1. Biofilms were developed as
previously described for C. albicans SC5314 using RPMI at pH 4 sup-
plemented or not with progesterone. Biofilms grown for 24h were
washed with PBS and imaged with ChemiDoc Image System (Bio-Rad,
Hercules, CA, USA). Additionally, gene expression of mutants biofilm
cells was analyzed by qRT-PCR. For that, biofilm formation, RNA ex-
traction and qRT-PCR procedures were performed as previously de-
scribed for qRT-PCR analyses of C. albicans SC5314. Primers for the
target genes were designed using Primer3 web software and their se-
quences are provided in supplementary Table S1.
2.7. Statistical analysis
Results of biofilm biomass, cells cultivability, metabolic activity and
gene expression (qRT-PCR) were statistically analyzed using t tests
implemented in GraphPad Prism 6 software. In all the experiments
three biological and technical replicates were performed. The statistical
tests were performed with a confidence level of 95 %.
3. Results and discussion
3.1. Effect of progesterone on C. albicans planktonic growth and biofilm
formation
To obtain a clearer picture of the effects exerted by progesterone on
the physiology of C. albicans we examined how the presence of this
hormone affects growth of the yeast cells, in either planktonic or bio-
film-forming conditions. The assays were performed in RPMI medium
at pH 4 in order to mimic the acidic vaginal environment (in the range
of 3.6–4.5) (Boskey, 2001). The medium was supplemented with 2 μM
of progesterone, which is the highest concentration reported in the
plasma of pregnant women in the third trimester (Alves et al., 2014), as
the hormonal disturbance promoted by pregnancy is considered an
important risk factor for VVC development (Sobel, 2007). In planktonic
conditions, the concentration of progesterone used had only a minor
effect on the growth rate of C. albicans SC5314 cells, comparatively to
what was observed in unsupplemented RPMI medium (supplementary
Fig. S1). However, the presence of progesterone reduced the ability of
C. albicans SC5314 to form biofilms, resulting in a statistically sig-
nificant decrease on cell cultivability (p-value ≤0.0001) and total
biomass (p-value ≤0.01) (Fig. 1A and B), compared to biofilms formed
in the absence of the hormone. Specifically, we observed a decrease in
the number of cultivable cells of approximately 2 orders of magnitude
[Log (CFUs/mL)/cm2] (Fig. 1A) and a decrease in biofilm biomass of
approximately 20 % (Fig. 1B). These results are consistent with those
reported by Alves et al. (2014). It is important to stress that the study of
Alves et al. (2014) was undertaken using two C. albicansstrains (ATCC
90028 and 558234), a reference strain from the American Type Culture
Collection and a vaginal isolate, respectively, different from the one
used in this study. This lead us to conclude that the inhibitory effect of
progesterone on biofilm formation by C. albicans is independent of the
genetic background of the strains used.
The effect of progesterone on the metabolic activity of C. albicans
biofilm’s cells was also evaluated, using XTT reduction assay. The re-
sults obtained (Fig. 1C) show a slight decrease in the metabolic activity
of biofilm cells cultivated in the presence of progesterone, compared to
the absence of the hormone; however, this difference is not statistically
significant (p-value>0.05). Progesterone also did not decrease meta-
bolic activity of planktonic cells (data not shown). The effect exerted by
progesterone on the structure and morphological characteristics of the
Fig. 4. (A) Sfl1 is required for maximal C. albicans biofilm formation under acidic conditions (pH 4); C. albicans homozygous mutant strain lacking SFL1 (sfl1Δ/sfl1Δ)
and the respective parental strain (SN76), were cultivated in RPMI at pH 4 for 24 h. The biofilms formed under these conditions were photographed and are shown.
(B) Effect of Sfl1 expression in transcription of NDT80, WOR1, NPL3 and TEC1 in biofilm cells after 24 h of cultivation in RPMI under the same conditions as those
used in the phenotypic assays shown in panel A. Error bars represent standard deviation. Asterisks represent statistical difference between the results of the mutant
and parent strain. (** p-value ≤0.01).
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biofilms formed by C. albicans was observed by SEM. In the absence of
progesterone C. albicans SC5314 cells formed a multilayer and compact
biofilm that covered the entire surface, constituted by a dense network
of hyphal forms (Fig. 1D). Differently, in the presence of 2 μM of pro-
gesterone, the biofilm consisted of a discontinuous multilayer with a
lower number of cells. These observations are consistent with the re-
duction in the number of cultivable cells (Fig. 1A) and total biomass
(Fig. 1B) of C. albicans SC5314 biofilms.
3.2. Transcriptional profiling of C. albicans cells present in biofilms formed
in the presence or absence of progesterone
To gain further insights into the molecular mechanisms by which
progesterone affects the physiology and response of C. albicans SC5314
cells, the transcriptomes of biofilms formed in the absence and presence
of progesterone were compared (after 24 h of cultivation in RPMI
medium at pH 4, either supplemented or not with 2 μM of the hor-
mone). Because a direct comparison of these two datasets could result
in the identification of genes responding to stimuli other than just
progesterone (e.g. to the acidic pH conditions used) we have compared
each set of biofilm cells against the transcriptome of planktonic C. al-
bicans SC5314 cells. By doing this we could identify in a first stage the
genes changing their expression in the biofilms formed under the acidic
conditions and afterwards use this information to pinpoint the pro-
gesterone-responsive genes. This setup also allowed us to obtain a
portrait of the transcriptome of mature biofilms formed by C. albicans
SC5314 in acidic conditions, something that, to our knowledge, had not
been performed before, since previous studies were performed using
biofilms formed in near-neutral pH (García-Sánchez et al., 2004;
Murillo et al., 2005; Yeater et al., 2007). Only genes whose transcripts
Table 3
Subset of progesterone-responsive genes in C. albicans SC5314 biofilms grown 24 h at pH 4. Was selected and listed here a subset of C. albicans SC5314 genes found be
up-regulated in biofilms grown 24 h in RPMI at pH 4, in the presence (+ PRG) and/or absence(- PRG) of 2 μM of progesterone and whose expression differed more
than 40 % between the two biofilm-forming conditions. This table includes a subset of genes found to be up-regulated in both conditions, but showing a stronger
induction in the presence of the hormone (group i) and a subset of genes strongly up-regulated in biofilms without progesterone than on its presence (group ii). The
full list of progesterone-responsive genes is available on supplementary Table S5. The biological function indicated is based on the information available at Candida
Genome Database.
Group i)
Gene Biological function mRNA +PRG mRNA -PRG mRNA +PRG/mRNA -PRG
ERG6 Protein involved in ergosterol biosynthesis 12.65 5.22 2.43
CDR2 Multidrug transporter of ABC superfamily 3.15 1.35 2.33
PGA31 Cell wall protein involved in response to drug 10.18 4.85 2.10
PGA45 Putative GPI-anchored cell wall protein 20.17 9.66 2.09
CDR1 Multidrug transporter of ABC superfamily 3.15 1.53 2.06
POT1 Putative peroxisomal 3-oxoacyl Co Athiolase 2.61 1.30 2.00
C3_02870C_A Unknown function 4.74 2.49 1.90
GAP2 General amino acid permease 2.14 1.18 1.82
ATO1 Putative transmembrane protein 7.62 4.31 1.77
C7_02260W_A Unknown function 3.23 1.85 1.74
INO1 Inositol-1-phosphate synthase 47.93 28.05 1.71
FAS2 Alpha subunit of fatty-acid synthase 2.43 1.44 1.68
C2_05980C_A Putative acyl-CoA hydrolase activity 3.17 1.89 1.68
PTH2 Putative cAMP-independent regulatory protein 3.60 2.19 1.64
AGP3 Putative serine transporter 5.12 3.20 1.60
C4_00250W_A Unknown function 3.48 2.18 1.59
FAT1 Predicted enzyme of sphingolipid biosynthesis 2.12 1.33 1.59
GIT2 Putative glycerol phosphoinositol permease 5.04 3.19 1.58
CSA2 Protein involved in iron assimilation 4.07 2.58 1.58
Group ii)
Gene Biological function mRNA +PRG mRNA -PRG mRNA +PRG/mRNA -PRG
COX3B Cytochrome c oxidase 1.54 10.97 0.14
NAD3 NADH dehydrogenase 1.38 9.49 0.15
ATP9 ATP synthase required for ATP synthesis 1.15 6.63 0.17
ATP6 ATP synthase required for ATP synthesis 1.52 7.84 0.19
NAD6 NADH dehydrogenase 1.69 8.54 0.20
COX2 Cytochrome c oxidase 1.76 8.56 0.21
WOR3 Transcription factor 0.85 2.63 0.32
SUT1 Zn2Cys6 transcription factor 0.96 2.16 0.44
BRG1 Transcription factor 0.89 2.01 0.44
RME1 Zinc finger protein; putative meiosis control 2.20 4.55 0.48
PRN3 Protein similar to pirin; unknown function 1.53 2.84 0.54
PRN1 Protein similar to pirin; unknown function 1.61 2.90 0.56
TEC1 TEA/ATTS transcription factor 3.20 5.64 0.57
PGA11 Putative GPI-anchored protein 1.16 2.03 0.57
TPK1 cAMP-dependent protein kinase 2.32 3.86 0.60
GIT1 Glycero phosphodiester transporter 1.30 2.14 0.60
C1_01130W_A Putative ubiquitin ligase complex component 1.99 3.24 0.61
WOR1 Transcription factor of phenotypic switching 1.32 2.16 0.61
IFE2 Putative alcohol dehydrogenase 1.50 2.41 0.62
SFL2 Transcription factor required for filament 1.79 2.84 0.63
HAP2 Transcription factor of low-iron induction 1.37 2.16 0.63
PBR1 Protein required for biofilm formation 2.51 3.92 0.64
SWE1 Putative protein kinase required for virulence 1.36 2.11 0.64
AHR1 Transcription factor involved in adhesion 1.76 2.62 0.67
HYR1 Hyphal cell wall protein involved in adhesion 6.82 9.87 0.69
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increased by more than 2-fold in the biofilm cells (in the presence or
absence of progesterone), in comparison the expression levels regis-
tered in planktonic cells, were considered. A more detailed analysis on
the observed transcriptome-wide alterations of C. albicans SC5314
biofilm cells follows.
3.3. Transcriptome-wide alterations of C. albicans biofilm cells under acidic
conditions
Transcriptional profiling of C. albicans biofilms formed after 24 h of
cultivation in acidic RPMI medium (at pH 4) showed a significant (p-
value below 0.01) alteration (above or below 2-fold) in the expression
of 1013 genes. Specifically, 616 genes were up-regulated in biofilm
cells, while 397 genes were down-regulated, in comparison with the
transcript levels observed in planktonic cells. A subset of these genes is
listed in Table 2 and the full list is available in supplementary Table S2.
About 322 of the up-regulated genes were previously shown to be in-
duced during biofilm formation by C. albicans (Desai et al., 2013;
García-Sánchez et al., 2004; Murillo et al., 2005; Nett et al., 2009;
Yeater et al., 2007). However, 294 genes are reported to be up-regu-
lated in biofilm cells for the first time (that is, these genes were not
reported to change their expression in other studies that examined
transcriptomic responses of C. albicans biofilm cells under other ex-
perimental conditions) suggesting that they can be responding to the
acidic environment (highlighted in grey in Table 2 and supplementary
Table S2). Notably, 8 of these newly identified biofilm-responsive genes
are essential for biofilm formation (highlighted in bold in Table 2 and
supplementary Table S2): NDT80 and WOR1, encoding two transcrip-
tional regulators (Nobile et al., 2012; Yi et al., 2011); ALS5, encoding
an adhesin (Garcia et al., 2011); the membrane protein PGA10; CSA2,
encoding a cell surface protein involved in iron utilization (Srikantha
et al., 2013), and the poorly characterized genes NPL3, C1_00160C_A
and C7_00490C_A (Bonhomme et al., 2011). Further studies will be
required to confirm whether or not the other newly identified biofilm
responsive genes also play a relevant role in the formation of biofilms
under acidic conditions.
To get a clearer picture of the alterations occurring in the genomic
expression of C. albicans biofilm cells under acidic conditions, the genes
up and down-regulated were functionally clustered using the MIPS
Functional catalogue (Fig. 2). The functional classes enriched (p-value
below 0.001) in the dataset of up-regulated genes were “transcription”,
“protein synthesis”, “protein with binding function” and “transport”.
On the other hand, down-regulated genes were enriched in functions
involved in “metabolism” (including enrichment of the subclasses
“amino acid”, “nitrogen”, “carbohydrate”, “lipid/fatty acid” and “sec-
ondary” metabolisms), “generation of energy”, “protein with binding
function”, “transport”, “stress response” and “interaction with the en-
vironment” (Fig. 2). In general, the functional clustering of the genes
found to be differently expressed in our acidic biofilms is similar to
those found in other studies (Desai et al., 2013; García-Sánchez et al.,
2004; Murillo et al., 2005; Nett et al., 2009; Yeater et al., 2007),
something that could be attributable to the fact that most of the genes
that we found differentially expressed in our acidic biofilms have a
poorly or even uncharacterized function.
To further understand the transcriptional regulatory network active
in the formation of biofilms under acidic conditions, we used the
PathoYeastract database (Monteiro et al., 2017)to cluster the up-regu-
lated genes with transcription factors reported to control the process of
biofilm formation in C. albicans (Ndt80, Efg1, Bcr1 and Tec1) (Nobile
et al., 2012). Approximately 33 % of the genes up-regulated in the
Fig. 5. Tec1-documented targets that were found to have a reduced expression in progesterone-exposed biofilm cells (A and B).The transcriptome-wide analysis
carried out led to the identification of a set of genes (fully detailed in supplementary Table S5) that were found to have a reduced expression in progesterone-exposed
biofilm cells, in comparison with the level attained in biofilms not exposed to the hormone. This set of genes included Tec1 and also a set of documented targets. (A)
In the picture are depicted all those documented Tec1 targets that have a biological function related to biofilm formation or whose expression was found to be
induced along biofilm formation. (B) The effect of Tec1 in up-regulating genes previously shown as relevant for C. albicans biofilm formation was tested by real-time
PCR, being confirmed the positive effect in the expression of PBR1, AHR1 and C7_01510w_A, both in absence of the hormone (-PRGST) and in progesterone-exposed
biofilm cells (+PRGST). Consistent with these results, Tec1 was found to be essential for formation of acidic biofilms and this phenotype was aggravated in the
presence of progesterone (C). Error bars represent standard deviation. Asterisks represent statistical difference between the results of the mutant and parent strain.
(**** p-value ≤0.0001; ** p-value ≤0.01).
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acidic biofilms are documented targets of Ndt80 transcription factor, 32
% of Efg1, 16 % of Bcr1, 13 % of Tec1 and 13 % of Brg1 (supplementary
Table S3). Fig. 3 shows the target genes of Efg1, Brg1, Bcr1 and Tec1
with differential expression under biofilm-forming conditions, ac-
cording with the information available on the PathoYeastract database
(Monteiro et al., 2017). A significant overlap between the genes regu-
lated by each transcription factor was observed, confirming the com-
plex and intertwined nature of the regulatory network controlling ex-
pression of biofilm genes in C. albicans (Nobile et al., 2012). The high
percentage of documented targets of CaNdt80 suggests that this reg-
ulator plays a particularly critical role in the control of expression under
these conditions. For 248 up-regulated genes we could not establish an
association with Efg1, Ndt80, Bcr1 and Tec1 and we have used the
PathoYeastract database again in order to identify what could be the
potential regulators of these genes. The results show that 160 of these
genes are targets of Sfl1. In fact, when we consider the entire dataset of
up-regulated genes Sfl1 is predicted to regulate 279 of these, which
surpasses the number of targets attributed to Efg1, Ndt80, Bcr1 or Tec1
(Fig. 3). These two observations suggest that this transcription factor
plays a role in formation of biofilms under acidic conditions, a hy-
pothesis that was confirmed when we compared the ability of wild-type
and sfl1Δ/sfl1Δ cells to form biofilms under acidic conditions (Fig. 4A).
Recently, Sfl1 was found to be required for formation of microcolonies
contributing to maximal adhesion to epithelial cells (McCall et al.,
2018). The involvement of Sfl1 in formation of acidic biofilms re-
presents a further insight into the biological function of this regulator.
The high overlap observed between the activated genes in our acidic
biofilms documented to be regulated by Sfl1 and Ndt80 prompted us to
test whether Sfl1 is a positive regulator of NDT80 expression. We found
that in acidic biofilms formed by the mutant sfl1Δ/sfl1Δ the expression
of NDT80 is approximately 10 % of the levels in the parental strain
(Fig. 4B). Previous studies have also shown that there is functional
interaction between Sfl1 and Ndt80 during hyphae formation in C. al-
bicans (Znaidi et al., 2013). Sfl1 was also found to be required for
maximal expression of NPL3 (Fig. 4B), which is up-regulated in acidic
biofilms, and has been shown to be an important determinant of biofilm
formation in C. albicans (Bonhomme et al., 2011). Further studies are
required to fully characterize the pH-dependent regulation of gene ex-
pression by Sfl1 during biofilm formation and, in particular, to identify
Sfl1-regulated targets that are essential for biofilm formation. Although
Sfl1 has been mostly described as a transcriptional repressor in C. al-
bicans (Bauer and Wendland, 2007; McCall et al., 2018), evidences from
chromatin immunoprecipitation profiling have shown that it also acts
as a positive regulator (Znaidi et al., 2013). Similarly, the ScSfl1 or-
thologue has also been found to have a dual effect acting both as a
positive and a negative regulator (Conlan and Tzamarias, 2001). The
molecular mechanisms driving the regulation of the activity of Sfl1
under the different environmental contexts that may control its activity
as an activator and/or repressor and how those environmental cues are
transduced into that regulatory mechanism remain to be established.
3.4. Transcriptome-wide alterations in C. albicans acidic biofilms in the
presence of progesterone
Transcriptome-wide profiling of C. albicans biofilms obtained after
24 h of cultivation in RPMI medium (at pH 4) supplemented with 2 μM
of progesterone identified a significant (p-value below 0.01) alteration
(above or below 2-fold) in the expression of 1057 genes (556 up- and
501 down-regulated), compared to the expression that was registered in
planktonic cells (supplementary Table S4). A large overlap between this
dataset and the dataset of genes differentially expressed in the biofilms
formed without progesterone (described above) was observed (sup-
plementary Fig. S2). This indicates that most of the changes observed in
the progesterone-exposed biofilms result from the process of biofilm
formation itself and not from the direct exposure to the hormone. We
have considered as progesterone-responsive genes only those whose
level of induction or repression in the presence of the hormone was 40
% higher than the levels registered in the absence of it. Using this cri-
terion, 220 progesterone-responsive genes could be identified, these
being afterwards divided in four groups: i) genes up-regulated in bio-
films formed in the presence or absence of progesterone, but showing a
stronger induction in the presence of the hormone (42 genes); ii) genes
more strongly up-regulated in biofilms formed without progesterone
(87 genes); iii) genes more strongly down-regulated in biofilms formed
without progesterone (12 genes); iv) genes more strongly down-regu-
lated in the progesterone-exposed biofilms (79 genes). A subset of these
progesterone-responsive genes is shown in Table 3 and the full list is
available in supplementary Table S5.
Closer analysis of the set of genes with higher induction in the
progesterone-exposed biofilms (clustered in group i) revealed a pro-
minent increase in transcription of CDR1 and CDR2, encoding two
multidrug resistance transporters of the ABC Superfamily (Table 3). The
up-regulation of CDR1 in response to progesterone in C. albicans biofilm
cells was further confirmed by qRT-PCR (supplementary Fig. S3). Other
studies have also reported up-regulation of CDR1 transcription upon
exposure of planktonic C. albicans cells to progesterone and to female
serum (Karnani et al., 2004; Larsen et al., 2006). Consistent with this
observation, planktonic progesterone-exposed cells are less sensitive to
fluconazole than cells cultivated in the absence of the hormone
(Banerjee et al., 2007; Larsen et al., 2006). Similarly, we observed that
progesterone-exposed biofilm cells were significantly more tolerant to
fluconazole than cells of biofilms developed in the absence of the
hormone (MIC of 1.5 μg/mL compared with 0.25 μg/mL).
The inhibitory effect of progesterone in biofilm formation may be
related to reduced expression of genes required for this process.
Expression of 166 progesterone-responsive genes is reduced in biofilm
cells grown with progesterone (87 clustered in group ii and 79 in group
iv (supplementary Table S5).These include several key regulators of
biofilm formation, including the transcription factors Tec1, Brg1, Ahr1,
Wor1, Csr1 and Crz2 (Askew et al., 2011; Finkel et al., 2012; Nobile
et al., 2012, 2009; Yi et al., 2011), the heat shock protein Hsp104 (Fiori
et al., 2012) and the uncharacterized protein Pbr1 (Sahni et al., 2009),
among other genes previously shown to be required for biofilm for-
mation (all highlighted in grey in supplementary Table S5). The pro-
gesterone-decreased expression of TEC1 and CRZ2 genes in C. albicans
biofilm cells was further confirmed by qRT-PCR (supplementary Fig.
S3).
Several genes involved in the process of biofilm formation that had
a reduced expression in the presence of progesterone are documented
targets of Tec1 (Fig. 5A) and Brg1, according to the PathoYeastract
database (Monteiro et al., 2017). We therefore tested whether these two
regulators are required for biofilm formation in the presence of the
hormone. Under the conditions that we have used only the deletion of
TEC1 had a significant effect in formation of acidic biofilms, this phe-
notype being further aggravated in the presence of progesterone
(Fig. 5C and results not shown for BRG1 deletion). Consistently, Tec1
was required for maximal expression of IFE2, PBR1 and C7_01510W_A,
either in the presence or absence of progesterone (Fig. 5B). Tec1 is also
required for maximal expression of HYR1 in progesterone-exposed
biofilm cells. However, in the absence of the hormone expression of
HYR1 is increased in the tec1Δ/tec1Δ mutant strain (Fig. 5B). This ob-
servation is a clear reflection of the complex nature of the regulatory
networks governing biofilm formation in C. albicans, which can be
greatly shaped by the environmental conditions.
4. Conclusions
Our study examined, for the first time, the alterations occurring in
the genomic expression of C. albicans during biofilm formation in acidic
conditions (RPMI at pH 4), which could potentially lead to the identi-
fication of novel players required for maximal biofilm formation in the
acidic vaginal tract. Indeed, we identified 286 genes whose
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transcription was changed during biofilm formation that have not
previously been associated with this process. These genes and their
regulators represent thus an interesting cohort to search for new players
involved in biofilm formation in the acidic vaginal tract. Using this
rationale, we showed that Sfl1 is essential for maximal biofilm forma-
tion and that is also likely to play a significant role in regulation of gene
expression in acidic-biofilm cells. In particular, Sfl1 regulates of Ndt80,
a major regulator of biofilm development. The impact of progesterone
exposure in biofilm formation and in genomic expression of biofilm-
forming C. albicans cells was also examined in our work for the first
time. The reduced ability to form biofilms observed upon exposure to
progesterone was consistent with the reduced transcription of several
key genes required for maximal biofilm formation, including the tran-
scriptional regulator Tec1 and several of its target genes. Progesterone
exposure was also found to significantly decrease the susceptibility of
biofilm cells to fluconazole, which is attributable to a reduction in ex-
pression of the drug-efflux pump CDR1. Considering that the vaginal
tract is one of the ma-in driveways for the development of C. albicans
infections, the identification of genes that may determine the ability of
this yeast to survive in specific vaginal conditions as the acidic pH or
progesterone presence may contribute to the disclosure of new targets
to treat VVC infections.
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